Investment Firms and Executives Purchase Shares in Tenax Therapeutics and Protagenic Therapeutics

Adar1 Capital Management has purchased $1.8 million in shares of Tenax Therapeutics, while Protagenic Therapeutics executive chair Garo Armen bought $13,000 in shares of his own company. These transactions indicate recent investment activity in both pharmaceutical firms.